Reporter

Shown here are members of the team working to evaluate new drug candidates for the treatment of kidney diseases.

Kidney diseases research collaboration renewed

Vanderbilt University Medical Center and Bayer have agreed to continue a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.

The four-bed epilepsy monitoring unit performs EEG-video monitoring, allowing neurologists to record seizures in order to determine the best treatment options. (photo by Donn Jones)

VWCH adds epilepsy monitoring unit, onsite neurologist

Vanderbilt Wilson County Hospital has added an epilepsy monitoring unit (EMU), with a neurologist onsite seeing patients in the hospital.

Heart Walk

The money is still rolling in, but so far last Saturday’s Greater Nashville Heart Walk has raised more than $1.6 million in its fight against heart disease and stroke as well as provide funding for public and professional education and community service programs.

Paper defines AI-related competencies for health professionals

Researchers at Vanderbilt University Medical Center and IBM Watson Health engaged experts from around the country in defining a set of AI-related clinical competencies for health care professionals.

Vanderbilt’s Terker wins NIH Director’s Early Independence Award

Andrew Terker, MD, PhD, a physician-scientist at Vanderbilt University Medical Center who is committed to advancing the understanding and treatment of kidney disease, has received a 2022 National Institutes of Health Director’s Early Independence Award.

Minority patients less likely to have amyloid plaques necessary for Alzheimer’s treatments

Fewer Black, Hispanic and Asian patients meet biomarker qualifications for landmark treatments that may slow the progression of Alzheimer’s disease by targeting amyloid plaques, according to new findings published in JAMA Neurology.

1 75 76 77 78 79 770